Literature DB >> 22863322

The effect of caffeine on retinal vessel diameter in young healthy subjects.

Naim Terai1, Eberhard Spoerl, Lutz E Pillunat, Richard Stodtmeister.   

Abstract

PURPOSE: To investigate the effect of caffeine on retinal vessel diameter before and during flicker light stimulation in young healthy subjects.
METHODS: Seventeen healthy subjects (mean age: 29.6 ± 3.73 years, range: 22-35 years) were included in this study. The diameter of retinal vessels was measured continuously with the retinal vessel analyzer (RVA) before and 1 hr after 200 mg oral caffeine intake. After baseline assessment, a green luminance flicker of 20-second duration was applied to stimulate retinal activity. The diameter of a segment of an arteriole and of a venule were measured during stimulation and 80 second after cessation of the stimulus. Flicker stimulation and 80-second measurement interval were carried out three times. Blood pressure parameters, systemic mean arterial pressure (MAP), ocular perfusion pressure (OPP) and intraocular pressure (IOP) were obtained before and after oral caffeine intake.
RESULTS: The mean diameter of the arterioles at baseline before caffeine intake was 123.30 ± 14.0 μm (arithmetic mean standard deviation) and after caffeine 117.30 ± 13.0 μm which was significantly different (p=0.004). The mean diameter of the venules at baseline before caffeine intake was 147.60 ± 19.5 μm and after caffeine 137.73 ± 19.9 μm which was significantly different (p = 0.005). The mean diameter of the arterioles during flicker light stimulation before caffeine intake was 126.65 ± 13.24 μm and after caffeine intake 121.59 ± 12.12 μm (p = 0.012). The mean diameter of the venules during flicker light stimulation before caffeine intake was 151.87 ± 18.63 μm and after caffeine intake was 145.14 ± 19.82 μm (p = 0.027). The flicker response of the arterioles increased from 2.8% before caffeine to 3.8% after caffeine intake (p = 0.010). The flicker response of the venules increased from 3.4% before caffeine to 5.5% after caffeine intake (p = 0.0001). Baseline diameters and diameters during flicker light stimulation after caffeine intake showed a significant negative correlation to the MAP for the arterioles (baseline: r = -0.338, p = 0.049 and flicker: r = -0.345, p = 0.046) and the venules (baseline: r = -0.496, p = 0.003 and flicker: r =-0.479, p = 0.004).
CONCLUSIONS: The present study showed a significant vasoconstrictory response of the retinal vessels 1 hr after caffeine intake in young healthy subjects. Retinal vessel diameter changes were negatively correlated with MAP after caffeine consumption. These effects seem to be elicited by an autoregulatory response of the retinal vessels to the increased blood pressure changes after caffeine.
© 2012 The Authors. Acta Ophthalmologica © 2012 Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22863322     DOI: 10.1111/j.1755-3768.2012.02486.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  20 in total

1.  Pulse waveform analysis on temporal changes in ocular blood flow due to caffeine intake: a comparative study between habitual and non-habitual groups.

Authors:  Aishah Ismail; Mehwish S Bhatti; Ibrahima Faye; Cheng Kai Lu; Augustinus Laude; Tong Boon Tang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-06       Impact factor: 3.117

2.  Inter-device reproducibility of retrobulbar blood flow velocity measurements in healthy subjects using color Doppler imaging.

Authors:  Verticchio Vercellin Alice C; Carlo A Cutolo; Carolina Dellafiore; Massimiliano Lava; Carmine Tinelli; Annalisa De Silvestri; Fabrizio Calliada; Giovanni Milano
Journal:  J Ultrasound       Date:  2016-02-01

3.  Retinal Vasculature Reactivity During Flicker Light Provocation, Cardiac Stress and Stroke Risk in Africans: The SABPA Study.

Authors:  Annemarie Wentzel; Leoné Malan; Wayne Smith; Roland von Känel; Nicolaas T Malan
Journal:  Transl Stroke Res       Date:  2018-11-09       Impact factor: 6.829

4.  Impaired retinal vasodilator responses in prediabetes and type 2 diabetes.

Authors:  Mary E J Lott; Julia E Slocomb; Vikram Shivkumar; Bruce Smith; David Quillen; Robert A Gabbay; Thomas W Gardner; Kerstin Bettermann
Journal:  Acta Ophthalmol       Date:  2013-06-07       Impact factor: 3.761

Review 5.  Caffeine and cardiovascular diseases: critical review of current research.

Authors:  Anthony Zulli; Renee M Smith; Peter Kubatka; Jan Novak; Yoshio Uehara; Hayley Loftus; Tawar Qaradakhi; Miroslav Pohanka; Nazarii Kobyliak; Angela Zagatina; Jan Klimas; Alan Hayes; Giampiero La Rocca; Miroslav Soucek; Peter Kruzliak
Journal:  Eur J Nutr       Date:  2016-03-01       Impact factor: 5.614

6.  Association of Caffeine Intake and Caffeinated Coffee Consumption With Risk of Incident Rosacea in Women.

Authors:  Suyun Li; Michael L Chen; Aaron M Drucker; Eunyoung Cho; Hao Geng; Abrar A Qureshi; Wen-Qing Li
Journal:  JAMA Dermatol       Date:  2018-12-01       Impact factor: 10.282

7.  Caffeine Modulates Spontaneous Adenosine and Oxygen Changes during Ischemia and Reperfusion.

Authors:  Ying Wang; B Jill Venton
Journal:  ACS Chem Neurosci       Date:  2018-10-09       Impact factor: 4.418

8.  The influence of roasting and additional processing on the content of bioactive components in special purpose coffees.

Authors:  Tadeusz Pilipczuk; Barbara Kusznierewicz; Danuta Zielińska; Agnieszka Bartoszek
Journal:  J Food Sci Technol       Date:  2014-11-26       Impact factor: 2.701

9.  Short-term effects of caffeine intake on anterior chamber angle and intraocular pressure in low caffeine consumers.

Authors:  Beatríz Redondo; Jesús Vera; Rubén Molina; Raimundo Jiménez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-10       Impact factor: 3.117

10.  Clinical Characteristics of Preterm Neonates with Aggressive Posterior Retinopathy of Prematurity.

Authors:  Nancy Abdel Salam Gomaa; Youssef A H Helmy; Sara Maher; Dina Hassanein; Asmaa Shuaib; Ahmed I Hegazy; Aliaa A Ali
Journal:  Clin Ophthalmol       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.